CDC20 and cancer: Compound 26 is a specific inhibitor of Cdc20, a protein which activates the key E3 ubiquitin ligase APC/C that controls cell cycle progression; Cdc20 is overexpressed in several cancers (see Reference [46] for a review of Cdc20 as an anticancer target).